iCo Therapeutics (OTCMKTS:ICOTF) Shares Down 46.9%

iCo Therapeutics Inc. (OTCMKTS:ICOTFGet Rating)’s stock price traded down 46.9% on Monday . The company traded as low as $0.35 and last traded at $0.35. 100 shares traded hands during trading, a decline of 98% from the average session volume of 4,760 shares. The stock had previously closed at $0.65.

The stock has a market cap of $3.12 million, a PE ratio of -0.86 and a beta of 2.03. The stock’s 50-day moving average is $0.70 and its two-hundred day moving average is $0.70.

About iCo Therapeutics (OTCMKTS:ICOTF)

Satellos Bioscience, Inc is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for iCo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.